Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Selected data for a company for 20x0 are as follows: Beginning stockholders equity.............. $5,000 Income before restructuring costs............. 1,000 At the end of 20x0, the
Selected data for a company for 20x0 are as follows:
Beginning stockholders equity.............. $5,000
Income before restructuring costs............. 1,000
At the end of 20x0, the company considers a major restructuring. Given the nature of the restructuring, the company has the flexibility to recognize the $300 restructuring cost either:
- As a $300 expense in 20x0, or
- As expenses of $150 in 20x1, $100 in 20x2, and $50 in 20x3.
Under the first alternative, net income will be $700 and ending stockholders equity will be $5,700. Under the second alternative, net income will be $1,000 and ending stockholders equity will be $6,000.
- Show that the EVA (abnormal earnings) valuation model is immune to the choice of accounting recognition methods. Assume that the valuation is made at the end of 20x0 and
- Income before restructuring costs will grow by $50 in each of the next three years.
- No dividends are paid.
- The cost of equity capital is 10%.
- Now assume that the valuation is made as of the beginning of 20x0 and the firm is already aware of its restructuring choices. Beginning book value of stockholders equity is $5,000 in both cases. However, 20x0 income differs with the accounting choice.
- Discuss whether EVAs (abnormal earnings) differ for years 20x1, 20x2, and 20x3.
- Show that the EVA valuation as of the beginning of 20x0 is also immune to the choice of recognition methods.
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started